Cargando…
Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
The treatment of multiple sclerosis (MS), the most common chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS), continues to transform. In recent years, a number of novel and increasingly effective disease‐modulatory therapies (DMTs) have been approve...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246813/ https://www.ncbi.nlm.nih.gov/pubmed/33258193 http://dx.doi.org/10.1111/joim.13215 |